Automated care pathway for inflammatory bowel disease
Part of Digestive system clinical trials.
This study uses an automated system to help manage care for people with inflammatory bowel disease (IBD) at UT Southwestern. It aims to see if this digital tool can improve treatment and follow-up for patients already taking IBD medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 2 visits to the UT Southwestern adult digestive disease clinic in the past 3 years, with at least 1 visit in the last 2 years.
- You are currently taking a medication specifically for inflammatory bowel disease.
- Your medical records show you have been diagnosed with inflammatory bowel disease (IBD) or have had at least two office visits or invoices for IBD care in the past 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app and activity tracker to monitor how people with Crohn's disease, ulcerative colitis, or unspecified IBD feel day to day. It may help doctors better understand and manage your condition through digital health data.
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
This trial tests a new treatment called CMTS0929 for people with inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It aims to see if the treatment works and is safe.
This study tests whether a smartphone app called SMART IBD can help children with IBD take their medications more consistently. It is for children who are currently missing more than 1 in 7 doses of their daily or weekly IBD medication.
This study tests if a mobile app can help manage your inflammatory bowel disease (IBD) from home. You may be eligible if you have IBD that has been active in the last two years and you are between 18 and 75 years old.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.